ASRT
Assertio Therapeutics Inc
NASDAQ: ASRT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$18.43
+2.11% today
Updated 2026-04-30
Market cap
$118.97M
P/E ratio
—
P/S ratio
1.00x
EPS (TTM)
$-4.74
Dividend yield
—
52W range
$9 – $20
Volume
0.2M
Assertio Therapeutics Inc (ASRT) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-25.60%
Operating margin
-105.20%
ROE
-28.20%
ROA
-3.90%
Debt/equity
0.37x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $9.55M | $-39.66M | 83.24% | -435.62% | -415.23% |
| 2007 | $65.58M | $49.22M | 96.04% | 72.49% | 75.05% |
| 2008 | $34.84M | $-15.30M | 83.43% | -49.06% | -43.92% |
| 2009 | $57.73M | $-22.01M | 90.89% | -38.23% | -38.12% |
| 2010 | $80.76M | $3.90M | 89.97% | 4.49% | 4.82% |
| 2011 | $132.97M | $70.73M | 95.83% | 53.17% | 53.19% |
| 2012 | $90.82M | $-29.78M | 93.35% | -33.42% | -32.79% |
| 2013 | $134.21M | $43.31M | 94.72% | 6.94% | 32.27% |
| 2014 | $390.36M | $131.76M | 96.12% | 60.67% | 33.75% |
| 2015 | $342.74M | $-75.74M | 80.19% | -14.71% | -22.10% |
| 2016 | $455.90M | $-88.72M | 80.83% | 5.38% | -19.46% |
| 2017 | $380.72M | $-102.50M | 80.93% | -11.08% | -26.92% |
| 2018 | $311.77M | $36.91M | 94.07% | 14.00% | 11.84% |
| 2019 | $229.53M | $-217.20M | 95.86% | -84.71% | -94.63% |
| 2020 | $108.08M | $-28.14M | 85.41% | -76.02% | -26.04% |
| 2021 | $111.01M | $-1.28M | 85.74% | 8.49% | -1.15% |
| 2022 | $156.23M | $109.63M | 88.00% | 25.22% | 70.17% |
| 2023 | $152.07M | $-331.94M | 82.23% | -160.15% | -218.28% |
| 2024 | $124.96M | $-21.58M | 68.61% | -19.59% | -17.27% |
| 2025 | $118.71M | $-29.50M | 70.19% | -18.14% | -24.85% |